Randall B. Riggs

Randall B. Riggs has over 22 years of business development experience within the pharmaceutical and biotechnology industries. Key points include over $14 million raised for phase I immunotherapy trials, approximately $1 billion raised in strategic partnership with multi-national firms including Hoffman-LaRoche, and over $200 million raised for a pharmaceutical IPO offering. Previous positions include executive positions with Advanced Cancer Therapeutics, BioCryst Pharmaceuticals, and Lexicon Pharmaceuticals.